Tango Therapeutics Inc (TNGX)

Nov 17, 2024

Trv Gp Iv LLC Has $129.82 Million Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 15, 2024

Nov 15, 2024

B. Riley Increases Earnings Estimates for Tango Therapeutics - Defense World

Nov 15, 2024

Nov 14, 2024

B. Riley Forecasts Higher Earnings for Tango Therapeutics - MarketBeat

Nov 14, 2024

Nov 14, 2024

B. Riley Cuts Tango Therapeutics (NASDAQ:TNGX) Price Target to $8.00 - Defense World

Nov 14, 2024

Nov 13, 2024

Tango Therapeutics' SWOT analysis: stock outlook amid PRMT5 inhibitor progress - Investing.com Canada

Nov 13, 2024

Nov 12, 2024

Tango Therapeutics (NASDAQ:TNGX) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 12, 2024

Nov 11, 2024

The Analyst Landscape: 5 Takes On Tango Therapeutics - Benzinga

Nov 11, 2024

Nov 11, 2024

B. Riley Has Lowered Expectations for Tango Therapeutics (NASDAQ:TNGX) Stock Price - MarketBeat

Nov 11, 2024

Nov 11, 2024

FY2024 Earnings Forecast for TNGX Issued By Leerink Partnrs - Defense World

Nov 11, 2024

Nov 09, 2024

EcoR1 Capital sells $8.4 million in Tango Therapeutics stock - Investing.com India

Nov 09, 2024

Nov 09, 2024

EcoR1 Capital sells $8.4 million in Tango Therapeutics stock By Investing.com - Investing.com Australia

Nov 09, 2024

Nov 09, 2024

Tango Therapeutics' (TNGX) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 09, 2024

Wedbush Has Pessimistic Outlook of TNGX FY2024 Earnings - Defense World

Nov 09, 2024

Nov 09, 2024

EcoR1 Capital, LLC Adjusts Stake in Tango Therapeutics Inc - GuruFocus.com

Nov 09, 2024

Nov 08, 2024

Wedbush Forecasts Reduced Earnings for Tango Therapeutics - MarketBeat

Nov 08, 2024

Nov 08, 2024

Tango Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 08, 2024

Nov 07, 2024

Tango Therapeutics sees $9.67m stock sale by Boxer Capital - Investing.com India

Nov 07, 2024

Nov 07, 2024

Tango Therapeutics (NASDAQ:TNGX) Price Target Lowered to $8.00 at Guggenheim - MarketBeat

Nov 07, 2024

Nov 07, 2024

Tango Therapeutics Advances Cancer Treatment Pipeline - TipRanks

Nov 07, 2024

Nov 06, 2024

Two to Tango: Brain cancer drugs go further into development - BioWorld Online

Nov 06, 2024

Nov 06, 2024

Tango stock plunges 28% amid pipeline updates, Q3 earnings report (NASDAQ:TNGX) - Seeking Alpha

Nov 06, 2024

Nov 06, 2024

U.S. Stock market: Sunnova energy(-42.35%0, Zoomcar(-38.48%), Tango therapeutics(-27.22%) among stock losers during early trading - Business Upturn

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics advances cancer drug into full development By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program - BioSpace

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics advances cancer drug into full development - Investing.com

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics Reports 43% Response Rate in Cancer Trial, Secures $293M Cash Runway | TNGX Stock News - StockTitan

Nov 06, 2024

Nov 06, 2024

Tango's TNG462 Cancer Drug Shows Promise; New Brain-Penetrant Treatment Unveiled | TNGX Stock News - StockTitan

Nov 06, 2024

Nov 04, 2024

Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week LowTime to Sell? - MarketBeat

Nov 04, 2024

Oct 31, 2024

Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - Simply Wall St

Oct 31, 2024

Oct 30, 2024

Tango Therapeutics (NASDAQ:TNGX) Stock Rating Reaffirmed by HC Wainwright - Defense World

Oct 30, 2024

Oct 30, 2024

Tango Therapeutics (NASDAQ:TNGX) Sets New 12-Month Low After Insider Selling - Defense World

Oct 30, 2024

Oct 29, 2024

Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month Low Following Insider Selling - MarketBeat

Oct 29, 2024

Oct 29, 2024

Tango Therapeutics (NASDAQ:TNGX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Oct 29, 2024

Oct 29, 2024

Tango Therapeutics target held at $13 by H.C. Wainwright - Investing.com

Oct 29, 2024

Oct 28, 2024

Tango Therapeutics (NASDAQ:TNGX) Sees Strong Trading VolumeHere's Why - MarketBeat

Oct 28, 2024

Oct 28, 2024

Short Interest in Tango Therapeutics, Inc. (NASDAQ:TNGX) Decreases By 17.7% - MarketBeat

Oct 28, 2024

Oct 28, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells $4,348,710.00 in Stock - MarketBeat

Oct 28, 2024

Oct 28, 2024

Tango Therapeutics (NASDAQ:TNGX) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 28, 2024

Oct 28, 2024

Tango Therapeutics sees $4.3 million stock sale by Boxer Capital - Investing.com Australia

Oct 28, 2024

Oct 25, 2024

Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 8.7%Time to Buy? - MarketBeat

Oct 25, 2024

Oct 24, 2024

Tango Therapeutics sees $6.1 million stock sale by Boxer Capital - Investing.com Australia

Oct 24, 2024

Oct 23, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Boxer Capital Management, Llc Sells 625,000 Shares - MarketBeat

Oct 23, 2024

Oct 23, 2024

Tango Therapeutics (NASDAQ:TNGX) Hits New 1-Year LowHere's What Happened - MarketBeat

Oct 23, 2024

Oct 23, 2024

Tango Therapeutics Inc (TNGX) Stock Price & Chart | Trade Now - Capital.com

Oct 23, 2024

Oct 23, 2024

Ares Management Co. (NYSE:ARES) Shares Acquired by Vontobel Holding Ltd. - Defense World

Oct 23, 2024

Oct 22, 2024

Tango Therapeutics (NASDAQ:TNGX) Trading Down 7.6%Time to Sell? - MarketBeat

Oct 22, 2024

Oct 21, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Oct 21, 2024